Targeted Oncology

Published by Springer

France · Lung Cancer Treatments and Mutations

Journal at a glance

ISSN

1776-2596

Publisher

Springer

Country

France

Language

en

Also known as: Target Oncol (Abbreviation)

Indexing

• Web of Science (SCIE): Indexed
• Scopus: Indexed
• Medline: Active
• Pubmed: Active

Metrics

Subjects

• Lung Cancer Treatments and Mutations
• Cancer Immunotherapy and Biomarkers
• Colorectal Cancer Treatments and Studies
• Lung Cancer Research Studies
• HER2/EGFR in Cancer Research
• Renal cell carcinoma treatment
• Cancer Genomics and Diagnostics

Articles on PubPorta

The most recent records PubPorta holds for this journal.

• FGF/FGFR Alteration Type as a Candidate Enrichment Biomarker for Gunagratinib in Recurrent or Metastatic Head and Neck Cancer: An Exploratory Analysis of Two Early-Phase Trials (2026)
• Baseline Disease Characteristics and Platinum Sensitivity as Predictors of Outcomes in Sequential Therapy with Platinum-Based Chemotherapy, Avelumab Maintenance, and Enfortumab Vedotin in Advanced Urothelial Carcinoma (ARON-2EV Study) (2026)
• Changing Treatment Landscape of Hepatocellular Carcinoma: A Real-World Retrospective Analysis of Treatment Algorithms and Outcomes of Patients over 10 Years (2026)
• Real-World Treatment Patterns in Advanced Cutaneous Melanoma in the USA (2026)
• From Recommendation to Implementation: Clinical Outcomes of a Single-Center Molecular Tumor Board (2026)

Similar journals

• Future Oncology — United Kingdom · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 6 shared subjects in total
• Oncologist — United Kingdom · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• JCO Precision Oncology — United States · — · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• Lung Cancer: Targets and Therapy — New Zealand · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• Forum of Clinical Oncology — Greece · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 5 shared subjects in total
• ESMO Open — Kingdom of the Netherlands · Open access · Same subject: Cancer Genomics and Diagnostics, Same subject: Cancer Immunotherapy and Biomarkers, 4 shared subjects in total

Sources: OpenAlex, NLM Catalog, Crossref, Web of Science (Clarivate), Scopus · Last verified 2026-09-05

Journal homepage